SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Sharp Corporation (SHCAY) trades at a trailing P/E of 0.1, forward P/E of 0.0. Trailing earnings yield is 1,666.67%, forward earnings yield 2,500.00%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.1); earnings yield beats bond yields (1,666.67%).
- Forward P/E 0.0 (down from trailing 0.1) — analysts expect earnings to grow, which would improve the valuation.
- Trailing Earnings Yield 1,666.67% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 2,500.00% as earnings recover.
Overall SharesGrow Score: 42/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SHCAY
Valuation Multiples
P/E (TTM)0.1
Forward P/E0.0
PEG RatioN/A
Forward PEG0.00
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$13.90
Forward EPS (Est.)$22.13
Book Value / Share$0.00
Revenue / Share$831.72
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1,666.67%
Forward Earnings Yield2,500.00%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-94.62 |
$2.46T |
$-255.97B |
-10.4% |
| 2017 |
$-3.52 |
$2.05T |
$-24.88B |
-1.2% |
| 2018 |
$7.19 |
$2.43T |
$70.23B |
2.9% |
| 2019 |
$7.60 |
$2.4T |
$74.23B |
3.1% |
| 2020 |
$8.25 |
$2.27T |
$20.96B |
0.9% |
| 2021 |
$21.80 |
$2.43T |
$53.26B |
2.2% |
| 2022 |
$30.29 |
$2.5T |
$73.99B |
3% |
| 2023 |
$-101.83 |
$2.55T |
$-260.84B |
-10.2% |
| 2024 |
$-57.75 |
$2.32T |
$-149.98B |
-6.5% |
| 2025 |
$13.90 |
$2.16T |
$36.1B |
1.7% |
